durapatite has been researched along with betadex in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, HT; Liu, XM; Marky, LA; Reinhardt, RA; Wang, D | 1 |
| Blanchemain, N; Chai, F; Flament, MP; Hildebrand, HF; Hoang Thi, TH; Leprêtre, S; Martel, B; Siepmann, F; Siepmann, J | 1 |
| Amiel, C; Dalmas, F; Sébille, B; Wintgens, V | 1 |
| Kim, YJ; Son, KD | 1 |
| Bae, MS; Balikov, DA; Heo, DN; Kim, JE; Kwon, IK; Lee, D; Lee, DW; Lee, JB; Rim, HJ; Sung, HJ | 1 |
| Jolly, R; Kazmi, S; Khan, MS; Rauf, A; Shakir, M | 1 |
| Han, Z; He, L; Li, H; Lu, X; Weng, J; Zhang, B; Zhi, W; Zhou, T | 1 |
| Azaroon, M; Kiasat, AR | 1 |
| Bian, Q; Chen, W; Du, J; Fu, D; Gan, S; Huang, D; Lin, Q; Wang, K; Wei, Y | 1 |
| Bingli, M; Chunyan, T; Haojie, D; Liping, S; Liuyun, J; Na, Z; Shengpei, S; Shuo, T; Yue, W | 1 |
| Molaei, MJ; Salimi, E | 1 |
| Chen, S; Jing, C; Li, B; Liang, H; Liu, C; Na, H; Tan, H; Zhang, C; Zhao, L | 1 |
| Chen, X; Gong, H; Guo, Z; Hu, D; Li, J; Mu, Y; Sun, T; Weng, J; Xin, Q | 1 |
13 other study(ies) available for durapatite and betadex
| Article | Year |
|---|---|
Novel biomineral-binding cyclodextrins for controlled drug delivery in the oral cavity.
Topics: Alendronate; beta-Cyclodextrins; Calorimetry; Delayed-Action Preparations; Dexamethasone; Drug Delivery Systems; Durapatite; Kinetics; Magnetic Resonance Spectroscopy; Mouth; Solubility | 2007 |
Bone implants modified with cyclodextrin: study of drug release in bulk fluid and into agarose gel.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Anti-Bacterial Agents; beta-Cyclodextrins; Bone Substitutes; Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Delivery Systems; Drug Stability; Durapatite; Gels; Kinetics; Sepharose; Vancomycin | 2010 |
Novel phosphorus-containing cyclodextrin polymers and their affinity for calcium cations and hydroxyapatite.
Topics: beta-Cyclodextrins; Calcium; Durapatite; Molecular Weight; Phosphorus; Polyphosphates | 2013 |
Morphological structure and characteristics of hydroxyapatite/β-cyclodextrin composite nanoparticles synthesized at different conditions.
Topics: beta-Cyclodextrins; Body Fluids; Crystallization; Durapatite; Nanoparticles; Particle Size; Spectrometry, X-Ray Emission; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Temperature; Thermogravimetry; X-Ray Diffraction | 2013 |
Poly(l-Lactic Acid)/Gelatin Fibrous Scaffold Loaded with Simvastatin/Beta-Cyclodextrin-Modified Hydroxyapatite Inclusion Complex for Bone Tissue Regeneration.
Topics: Animals; beta-Cyclodextrins; Bone Development; Cell Differentiation; Durapatite; Gelatin; Humans; Osteogenesis; Polyesters; Rabbits; Simvastatin; Tissue Engineering; Tissue Scaffolds; Wound Healing | 2016 |
Nano-hydroxyapatite/β-CD/chitosan nanocomposite for potential applications in bone tissue engineering.
Topics: Alkaline Phosphatase; Anti-Bacterial Agents; beta-Cyclodextrins; Biocompatible Materials; Bone and Bones; Cell Line; Chitosan; Compressive Strength; Durapatite; Hardness; Hemolysis; Humans; Nanocomposites; Tissue Engineering; Tissue Scaffolds | 2016 |
Surface-decorated hydroxyapatite scaffold with on-demand delivery of dexamethasone and stromal cell derived factor-1 for enhanced osteogenesis.
Topics: Alkaline Phosphatase; Animals; beta-Cyclodextrins; Bone Marrow Cells; Bone Regeneration; Cell Differentiation; Chemokine CXCL12; Core Binding Factor Alpha 1 Subunit; Dexamethasone; Dogs; Drug Carriers; Durapatite; Male; Mesenchymal Stem Cells; Microspheres; Osteogenesis; Porosity; Rats; Rats, Sprague-Dawley; Tissue Engineering | 2018 |
β-Cyclodextrin engineered γ-Fe
Topics: Acetophenones; beta-Cyclodextrins; Durapatite; Ferric Compounds; Nanocomposites; Nitrogen; Spectrometry, X-Ray Emission; Spectroscopy, Fourier Transform Infrared; Temperature; Thermogravimetry; X-Ray Diffraction | 2018 |
Preparation and characterization of porous hydroxyapatite/β-cyclodextrin-based polyurethane composite scaffolds for bone tissue engineering.
Topics: Animals; beta-Cyclodextrins; Bone Regeneration; Bone Substitutes; Cell Line; Durapatite; Mice; Osteogenesis; Polyurethanes; Porosity; Tissue Engineering; Tissue Scaffolds | 2018 |
A combined-modification method of carboxymethyl β-cyclodextrin and lignin for nano-hydroxyapatite to reinforce poly(lactide-co-glycolide) for bone materials.
Topics: Animals; beta-Cyclodextrins; Biocompatible Materials; Bone and Bones; Cells, Cultured; Durapatite; Lignin; Mesenchymal Stem Cells; Mice; Nanocomposites; Nanoparticles; Polyglactin 910; Tensile Strength; X-Ray Diffraction | 2020 |
Preparation and in-vitro evaluation of β-CD/HA nanocomposite as a potential carrier for hydrophobic drugs.
Topics: beta-Cyclodextrins; Dexamethasone; Drug Carriers; Drug Liberation; Durapatite; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Nanocomposites | 2021 |
Alendronate-Decorated Nanoparticles as Bone-Targeted Alendronate Carriers for Potential Osteoporosis Treatment.
Topics: Alendronate; Alginates; Animals; beta-Cyclodextrins; Bone and Bones; Bone Density Conservation Agents; Cell Line; Cell Survival; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Durapatite; Erythrocytes; Goats; Hemolysis; Mice; Nanoparticles; Osteoporosis; Polylactic Acid-Polyglycolic Acid Copolymer | 2021 |
Hexapeptide decorated β-cyclodextrin delivery system for targeted therapy of bone infection.
Topics: Animals; Anti-Bacterial Agents; beta-Cyclodextrins; Drug Delivery Systems; Durapatite; Mice; Mice, Nude; Osteomyelitis; Pharmaceutical Preparations; Polyethylene Glycols; Rats | 2023 |